Nonadherence to topical therapies for psoriasis is common. Reasons include miscommunication or inadequate communication between patients and clinicians, a mismatch between physician and patient treatment priorities, the complexity of treatment regimens, and a lack of information conveyed to the patient about realistic expectations from therapy. Interventions to facilitate communication and education are available to support clinicians and patients
Abstract Background Psoriasis affects 2–4% of the Western adult population and is a socio-economic b...
Background: Medication nonadherence is known to limit the effectiveness of available therapies; howe...
Background: Psoriasis is a multifactorial disease that effect approximately 7.5 million Americans. T...
Patient outcomes and clinical improvement are closely related to topical medication adherence, and i...
Topical therapy has an important role in psoriasis treatment. It is efficacious and has a favorable ...
Psoriasis is a frequent inflammatory disease with a chronic and relapsing course. Therefore, patient...
Psoriasis is a chronic disease that has a substantial effect on quality of life of patients and ofte...
Psoriasis is one of the most important inflammatory cutaneous diseases with a profound effect on a p...
Topical treatments are frequently used for the therapy of psoriasis. However, they may be associated...
Topical treatments are frequently used for the therapy of psoriasis. However, they may be associated...
International audienceBACKGROUND: Treatment adherence has been recognized as an important issue in t...
Poor adherence to topical therapy, defined as the degree to which patients use medication as prescri...
Topical treatment is the cornerstone of therapy for patients suffering from psoriasis. Its efficacy ...
Therapeutic alliance between the patient and the physician plays a primary role in the patient-docto...
Several topical treatments are available for patients with psoriasis. Although individualization of ...
Abstract Background Psoriasis affects 2–4% of the Western adult population and is a socio-economic b...
Background: Medication nonadherence is known to limit the effectiveness of available therapies; howe...
Background: Psoriasis is a multifactorial disease that effect approximately 7.5 million Americans. T...
Patient outcomes and clinical improvement are closely related to topical medication adherence, and i...
Topical therapy has an important role in psoriasis treatment. It is efficacious and has a favorable ...
Psoriasis is a frequent inflammatory disease with a chronic and relapsing course. Therefore, patient...
Psoriasis is a chronic disease that has a substantial effect on quality of life of patients and ofte...
Psoriasis is one of the most important inflammatory cutaneous diseases with a profound effect on a p...
Topical treatments are frequently used for the therapy of psoriasis. However, they may be associated...
Topical treatments are frequently used for the therapy of psoriasis. However, they may be associated...
International audienceBACKGROUND: Treatment adherence has been recognized as an important issue in t...
Poor adherence to topical therapy, defined as the degree to which patients use medication as prescri...
Topical treatment is the cornerstone of therapy for patients suffering from psoriasis. Its efficacy ...
Therapeutic alliance between the patient and the physician plays a primary role in the patient-docto...
Several topical treatments are available for patients with psoriasis. Although individualization of ...
Abstract Background Psoriasis affects 2–4% of the Western adult population and is a socio-economic b...
Background: Medication nonadherence is known to limit the effectiveness of available therapies; howe...
Background: Psoriasis is a multifactorial disease that effect approximately 7.5 million Americans. T...